Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLMT - US1314281049 - Common Stock

20.56 USD
+0.46 (+2.29%)
Last: 1/15/2026, 8:00:00 PM
20.56 USD
0 (0%)
After Hours: 1/15/2026, 8:00:00 PM
Fundamental Rating

2

CLMT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 208 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. CLMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CLMT has reported negative net income.
  • In the past year CLMT has reported a negative cash flow from operations.
  • CLMT had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CLMT reported negative operating cash flow in multiple years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • CLMT's Return On Assets of -1.36% is on the low side compared to the rest of the industry. CLMT is outperformed by 72.12% of its industry peers.
  • CLMT's Return On Invested Capital of 5.73% is in line compared to the rest of the industry. CLMT outperforms 51.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLMT is significantly below the industry average of 21.83%.
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC 5.73%
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

  • CLMT has a Operating Margin of 3.51%. This is in the lower half of the industry: CLMT underperforms 66.83% of its industry peers.
  • CLMT's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 8.21%, CLMT is not doing good in the industry: 72.60% of the companies in the same industry are doing better.
  • CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.51%
PM (TTM) N/A
GM 8.21%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLMT is destroying value.
  • CLMT has more shares outstanding than it did 1 year ago.
  • CLMT has more shares outstanding than it did 5 years ago.
  • CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.22, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.22, CLMT perfoms like the industry average, outperforming 49.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACC0.58
WACC9.96%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • CLMT has a Current Ratio of 1.13. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CLMT (1.13) is comparable to the rest of the industry.
  • A Quick Ratio of 0.62 indicates that CLMT may have some problems paying its short term obligations.
  • CLMT has a Quick ratio of 0.62. This is in the lower half of the industry: CLMT underperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.33% over the past year.
  • Looking at the last year, CLMT shows a very negative growth in Revenue. The Revenue has decreased by -22.49% in the last year.
  • Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%

3.2 Future

  • Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.17% on average per year.
  • CLMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.84% yearly.
EPS Next Y94.2%
EPS Next 2Y41.83%
EPS Next 3Y30.53%
EPS Next 5Y29.17%
Revenue Next Year1.96%
Revenue Next 2Y-0.25%
Revenue Next 3Y5.96%
Revenue Next 5Y5.84%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

1

4. Valuation

4.1 Price/Earnings Ratio

  • CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 671.90, which means the current valuation is very expensive for CLMT.
  • 67.79% of the companies in the same industry are cheaper than CLMT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.31. CLMT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 671.9
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than the industry average as 65.87% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.03
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLMT does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as CLMT's earnings are expected to grow with 30.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.83%
EPS Next 3Y30.53%

0

5. Dividend

5.1 Amount

  • CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CALUMET INC

NASDAQ:CLMT (1/15/2026, 8:00:00 PM)

After market: 20.56 0 (0%)

20.56

+0.46 (+2.29%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners52.96%
Inst Owner Change0.02%
Ins Owners2.98%
Ins Owner Change-0.16%
Market Cap1.78B
Revenue(TTM)4.05B
Net Income(TTM)-37.20M
Analysts78.33
Price Target22.25 (8.22%)
Short Float %11.64%
Short Ratio11.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)369.74%
Min EPS beat(2)-407.62%
Max EPS beat(2)1147.11%
EPS beat(4)2
Avg EPS beat(4)105.83%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)44.84%
EPS beat(12)6
Avg EPS beat(12)-404.2%
EPS beat(16)6
Avg EPS beat(16)-335.84%
Revenue beat(2)2
Avg Revenue beat(2)4.63%
Min Revenue beat(2)0.47%
Max Revenue beat(2)8.78%
Revenue beat(4)4
Avg Revenue beat(4)4.89%
Min Revenue beat(4)0.47%
Max Revenue beat(4)9.31%
Revenue beat(8)8
Avg Revenue beat(8)7.08%
Revenue beat(12)11
Avg Revenue beat(12)7.22%
Revenue beat(16)15
Avg Revenue beat(16)10.04%
PT rev (1m)0%
PT rev (3m)8.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-71.18%
EPS NY rev (1m)77.27%
EPS NY rev (3m)96.55%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)-4.59%
Revenue NY rev (1m)1.76%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 671.9
P/S 0.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14.03
EPS(TTM)-1.15
EYN/A
EPS(NY)0.03
Fwd EY0.15%
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS46.66
BVpS-8.01
TBVpS-8.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE 7.26%
ROIC 5.73%
ROICexc 6.03%
ROICexgc 6.03%
OM 3.51%
PM (TTM) N/A
GM 8.21%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
ROICexc(3y)7.12%
ROICexc(5y)N/A
ROICexgc(3y)8.23%
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.77%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.65%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.38
Cap/Depr 43.36%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.22
F-Score4
WACC9.96%
ROIC/WACC0.58
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
EPS Next Y94.2%
EPS Next 2Y41.83%
EPS Next 3Y30.53%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%
Revenue Next Year1.96%
Revenue Next 2Y-0.25%
Revenue Next 3Y5.96%
Revenue Next 5Y5.84%
EBIT growth 1Y1018.9%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3138.83%
EBIT Next 3Y274.32%
EBIT Next 5Y148.39%
FCF growth 1Y83.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALUMET INC / CLMT FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


Can you provide the profitability details for CALUMET INC?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CALUMET INC?

The Earnings per Share (EPS) of CALUMET INC (CLMT) is expected to grow by 94.2% in the next year.


Is the dividend of CALUMET INC sustainable?

The dividend rating of CALUMET INC (CLMT) is 0 / 10 and the dividend payout ratio is 0%.